Secukinumab (anti-IL-17A)

Ask supplier a question | View on supplier's website

Secukinumab (anti-IL-17A) (Cosentyx, AIN457) is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is applied for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. MW=147.9 kDa.

Supplier	Selleck Chemicals
Product #	A2025
Sku #	A2025-1mg*5
Pricing	1mg*5, $707.00

Feedback